Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Inspire Medical Systems, Inc.INSP · Entity 1186 | Director | July 16, 2019 | July 19, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Inspire Medical Systems, Inc.
Report date July 16, 2019 · Filed July 19, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectSee Footnote | 103,939 |
Last balance in matching sequence
After 2019-07-18 transaction · row 3
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
3 source rowsRow 1 · 2019-07-16 · Sale · Disposed 22,738 · Balance 197,653 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Amzak Health Investors, LLC ("Amzak Health") on June 4, 2019. F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.50 to $68.88. The reporting person undertakes to provide Inspire Medical Systems, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F5: These shares are held of record by Amzak Health. The reporting person, a director of the Issuer, and Michael D. Kazma are managers of Amzak Health and, as a result, have shared voting and dispositive power over the shares held by Amzak Health. Ms. Erony disclaims beneficial ownership of the shares held by Amzak Health except to the extent of her proportionate pecuniary interest therein. Row 2 · 2019-07-17 · Sale · Disposed 53,964 · Balance 143,689 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Amzak Health Investors, LLC ("Amzak Health") on June 4, 2019. F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.50 to $68.755. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F5: These shares are held of record by Amzak Health. The reporting person, a director of the Issuer, and Michael D. Kazma are managers of Amzak Health and, as a result, have shared voting and dispositive power over the shares held by Amzak Health. Ms. Erony disclaims beneficial ownership of the shares held by Amzak Health except to the extent of her proportionate pecuniary interest therein. Row 3 · 2019-07-18 · Sale · Disposed 39,750 · Balance 103,939 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Amzak Health Investors, LLC ("Amzak Health") on June 4, 2019. F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.50 to $68.52. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F5: These shares are held of record by Amzak Health. The reporting person, a director of the Issuer, and Michael D. Kazma are managers of Amzak Health and, as a result, have shared voting and dispositive power over the shares held by Amzak Health. Ms. Erony disclaims beneficial ownership of the shares held by Amzak Health except to the extent of her proportionate pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Amzak Health Investors, LLC ("Amzak Health") on June 4, 2019.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.50 to $68.88. The reporting person undertakes to provide Inspire Medical Systems, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.50 to $68.755. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.50 to $68.52. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5: These shares are held of record by Amzak Health. The reporting person, a director of the Issuer, and Michael D. Kazma are managers of Amzak Health and, as a result, have shared voting and dispositive power over the shares held by Amzak Health. Ms. Erony disclaims beneficial ownership of the shares held by Amzak Health except to the extent of her proportionate pecuniary interest therein.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 18, 2019 Filed Jul 19, 2019 00:41 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 39,750 | $67.97 | $2,701,835.33 |
DisclosureSEC source: 0001213900-19-013152 · ownership.xml · nonDerivative · entry 3 Erony Joyce · CIK 0001459212 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 103,939 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Amzak Health Investors, LLC ("Amzak Health") on June 4, 2019. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.50 to $68.52. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F5 · ownership.nature: These shares are held of record by Amzak Health. The reporting person, a director of the Issuer, and Michael D. Kazma are managers of Amzak Health and, as a result, have shared voting and dispositive power over the shares held by Amzak Health. Ms. Erony disclaims beneficial ownership of the shares held by Amzak Health except to the extent of her proportionate pecuniary interest therein. Read SEC document |
| July 17, 2019 Filed Jul 19, 2019 00:41 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 53,964 | $68.28 | $3,684,721.28 |
DisclosureSEC source: 0001213900-19-013152 · ownership.xml · nonDerivative · entry 2 Erony Joyce · CIK 0001459212 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 143,689 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Amzak Health Investors, LLC ("Amzak Health") on June 4, 2019. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.50 to $68.755. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F5 · ownership.nature: These shares are held of record by Amzak Health. The reporting person, a director of the Issuer, and Michael D. Kazma are managers of Amzak Health and, as a result, have shared voting and dispositive power over the shares held by Amzak Health. Ms. Erony disclaims beneficial ownership of the shares held by Amzak Health except to the extent of her proportionate pecuniary interest therein. Read SEC document |
| July 16, 2019 Filed Jul 19, 2019 00:41 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 22,738 | $68.27 | $1,552,291.43 |
DisclosureSEC source: 0001213900-19-013152 · ownership.xml · nonDerivative · entry 1 Erony Joyce · CIK 0001459212 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 197,653 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Amzak Health Investors, LLC ("Amzak Health") on June 4, 2019. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.50 to $68.88. The reporting person undertakes to provide Inspire Medical Systems, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F5 · ownership.nature: These shares are held of record by Amzak Health. The reporting person, a director of the Issuer, and Michael D. Kazma are managers of Amzak Health and, as a result, have shared voting and dispositive power over the shares held by Amzak Health. Ms. Erony disclaims beneficial ownership of the shares held by Amzak Health except to the extent of her proportionate pecuniary interest therein. Read SEC document |
| July 15, 2019 Filed Jul 16, 2019 00:17 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 52,866 | $68.60 | $3,626,438.43 |
DisclosureSEC source: 0001213900-19-012782 · ownership.xml · nonDerivative · entry 3 Erony Joyce · CIK 0001459212 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 220,391 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Amzak Health Investors, LLC ("Amzak Health") on June 4, 2019. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.16 to $69.29. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F5 · ownership.nature: These shares are held of record by Amzak Health. The reporting person, a director of the Issuer, and Michael D. Kazma are managers of Amzak Health and, as a result, have shared voting and dispositive power over the shares held by Amzak Health. Ms. Erony disclaims beneficial ownership of the shares held by Amzak Health except to the extent of her proportionate pecuniary interest therein. Read SEC document |
| July 12, 2019 Filed Jul 16, 2019 00:17 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 41,075 | $66.63 | $2,736,905.29 |
DisclosureSEC source: 0001213900-19-012782 · ownership.xml · nonDerivative · entry 2 Erony Joyce · CIK 0001459212 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 273,257 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Amzak Health Investors, LLC ("Amzak Health") on June 4, 2019. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.24 to $67.75. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F5 · ownership.nature: These shares are held of record by Amzak Health. The reporting person, a director of the Issuer, and Michael D. Kazma are managers of Amzak Health and, as a result, have shared voting and dispositive power over the shares held by Amzak Health. Ms. Erony disclaims beneficial ownership of the shares held by Amzak Health except to the extent of her proportionate pecuniary interest therein. Read SEC document |
| July 11, 2019 Filed Jul 16, 2019 00:17 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 31,519 | $66.79 | $2,105,163.47 |
DisclosureSEC source: 0001213900-19-012782 · ownership.xml · nonDerivative · entry 1 Erony Joyce · CIK 0001459212 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 314,332 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Amzak Health Investors, LLC ("Amzak Health") on June 4, 2019. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.57 to $67.51. The reporting person undertakes to provide Inspire Medical Systems, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F5 · ownership.nature: These shares are held of record by Amzak Health. The reporting person, a director of the Issuer, and Michael D. Kazma are managers of Amzak Health and, as a result, have shared voting and dispositive power over the shares held by Amzak Health. Ms. Erony disclaims beneficial ownership of the shares held by Amzak Health except to the extent of her proportionate pecuniary interest therein. Read SEC document |
| July 10, 2019 Filed Jul 11, 2019 00:04 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 54,715 | $66.70 | $3,649,430.31 |
DisclosureSEC source: 0001213900-19-012464 · ownership.xml · nonDerivative · entry 3 Erony Joyce · CIK 0001459212 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 345,851 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Amzak Health Investors, LLC ("Amzak Health") on June 4, 2019. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.75 to $67.735. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F5 · ownership.nature: These shares are held of record by Amzak Health. The reporting person, a director of the Issuer, and Michael D. Kazma are managers of Amzak Health and, as a result, have shared voting and dispositive power over the shares held by Amzak Health. Ms. Erony disclaims beneficial ownership of the shares held by Amzak Health except to the extent of her proportionate pecuniary interest therein. Read SEC document |
| July 09, 2019 Filed Jul 11, 2019 00:04 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 38,122 | $65.77 | $2,507,444.05 |
DisclosureSEC source: 0001213900-19-012464 · ownership.xml · nonDerivative · entry 2 Erony Joyce · CIK 0001459212 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 400,566 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Amzak Health Investors, LLC ("Amzak Health") on June 4, 2019. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.465 to $66.45. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F5 · ownership.nature: These shares are held of record by Amzak Health. The reporting person, a director of the Issuer, and Michael D. Kazma are managers of Amzak Health and, as a result, have shared voting and dispositive power over the shares held by Amzak Health. Ms. Erony disclaims beneficial ownership of the shares held by Amzak Health except to the extent of her proportionate pecuniary interest therein. Read SEC document |
| July 08, 2019 Filed Jul 11, 2019 00:04 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 98,355 | $67.60 | $6,648,335.73 |
DisclosureSEC source: 0001213900-19-012464 · ownership.xml · nonDerivative · entry 1 Erony Joyce · CIK 0001459212 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 438,688 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Amzak Health Investors, LLC ("Amzak Health") on June 4, 2019. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.14 to $69.61. The reporting person undertakes to provide Inspire Medical Systems, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F5 · ownership.nature: These shares are held of record by Amzak Health. The reporting person, a director of the Issuer, and Michael D. Kazma are managers of Amzak Health and, as a result, have shared voting and dispositive power over the shares held by Amzak Health. Ms. Erony disclaims beneficial ownership of the shares held by Amzak Health except to the extent of her proportionate pecuniary interest therein. Read SEC document |
| May 31, 2019 Filed Jun 4, 2019 12:34 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 34,495 | $56.05 | $1,933,358.51 |
DisclosureSEC source: 0001213900-19-010008 · ownership.xml · nonDerivative · entry 2 Erony Joyce · CIK 0001459212 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 537,043 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.31 to $56.72. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are held of record by Amzak Health Investors LLC ("Amzak Health"). The reporting person, a director of the Issuer, and Michael D. Kazma are managers of Amzak Health and, as a result, have shared voting and dispositive power over the shares held by Amzak Health. Ms. Erony disclaims beneficial ownership of the shares held by Amzak Health except to the extent of her proportionate pecuniary interest therein. Read SEC document |
| May 30, 2019 Filed Jun 4, 2019 12:34 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 32,073 | $55.43 | $1,777,928.27 |
DisclosureSEC source: 0001213900-19-010008 · ownership.xml · nonDerivative · entry 1 Erony Joyce · CIK 0001459212 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 571,538 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.53 to $57.01. The reporting person undertakes to provide Inspire Medical Systems, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are held of record by Amzak Health Investors LLC ("Amzak Health"). The reporting person, a director of the Issuer, and Michael D. Kazma are managers of Amzak Health and, as a result, have shared voting and dispositive power over the shares held by Amzak Health. Ms. Erony disclaims beneficial ownership of the shares held by Amzak Health except to the extent of her proportionate pecuniary interest therein. Read SEC document |
| May 29, 2019 Filed May 30, 2019 01:53 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 20,449 | $54.39 | $1,112,129.09 |
DisclosureSEC source: 0001213900-19-009744 · ownership.xml · nonDerivative · entry 3 Erony Joyce · CIK 0001459212 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 603,611 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.01 to $54.98. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 · ownership.nature: These shares are held of record by Amzak Health Investors LLC ("Amzak Health"). The reporting person, a director of the Issuer, and Michael D. Kazma are managers of Amzak Health and, as a result, have shared voting and dispositive power over the shares held by Amzak Health. Ms. Erony disclaims beneficial ownership of the shares held by Amzak Health except to the extent of her proportionate pecuniary interest therein. Read SEC document |
| May 28, 2019 Filed May 30, 2019 01:53 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 600 | $54.12 | $32,470.02 |
DisclosureSEC source: 0001213900-19-009744 · ownership.xml · nonDerivative · entry 2 Erony Joyce · CIK 0001459212 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 624,060 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.00 to $54.18. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 · ownership.nature: These shares are held of record by Amzak Health Investors LLC ("Amzak Health"). The reporting person, a director of the Issuer, and Michael D. Kazma are managers of Amzak Health and, as a result, have shared voting and dispositive power over the shares held by Amzak Health. Ms. Erony disclaims beneficial ownership of the shares held by Amzak Health except to the extent of her proportionate pecuniary interest therein. Read SEC document |
| May 24, 2019 Filed May 30, 2019 01:53 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 23,004 | $54.17 | $1,246,225.60 |
DisclosureSEC source: 0001213900-19-009744 · ownership.xml · nonDerivative · entry 1 Erony Joyce · CIK 0001459212 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 624,660 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.00 to $54.50. The reporting person undertakes to provide Inspire Medical Systems, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 · ownership.nature: These shares are held of record by Amzak Health Investors LLC ("Amzak Health"). The reporting person, a director of the Issuer, and Michael D. Kazma are managers of Amzak Health and, as a result, have shared voting and dispositive power over the shares held by Amzak Health. Ms. Erony disclaims beneficial ownership of the shares held by Amzak Health except to the extent of her proportionate pecuniary interest therein. Read SEC document |
| May 23, 2019 Filed May 24, 2019 01:57 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 137 | $54.00 | $7,398.00 |
DisclosureSEC source: 0001213900-19-009526 · ownership.xml · nonDerivative · entry 3 Erony Joyce · CIK 0001459212 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 647,664 F3 · ownership.nature: These shares are held of record by Amzak Health Investors LLC ("Amzak Health"). The reporting person, a director of the Issuer, and Michael D. Kazma are managers of Amzak Health and, as a result, have shared voting and dispositive power over the shares held by Amzak Health. Ms. Erony disclaims beneficial ownership of the shares held by Amzak Health except to the extent of her proportionate pecuniary interest therein. Read SEC document |
| May 22, 2019 Filed May 24, 2019 01:57 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 26,388 | $54.38 | $1,434,947.77 |
DisclosureSEC source: 0001213900-19-009526 · ownership.xml · nonDerivative · entry 2 Erony Joyce · CIK 0001459212 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 647,801 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.01 to $54.75. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are held of record by Amzak Health Investors LLC ("Amzak Health"). The reporting person, a director of the Issuer, and Michael D. Kazma are managers of Amzak Health and, as a result, have shared voting and dispositive power over the shares held by Amzak Health. Ms. Erony disclaims beneficial ownership of the shares held by Amzak Health except to the extent of her proportionate pecuniary interest therein. Read SEC document |
| May 21, 2019 Filed May 24, 2019 01:57 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 12,854 | $54.82 | $704,606.15 |
DisclosureSEC source: 0001213900-19-009526 · ownership.xml · nonDerivative · entry 1 Erony Joyce · CIK 0001459212 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 674,189 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.565 to $54.9775. The reporting person undertakes to provide Inspire Medical Systems, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are held of record by Amzak Health Investors LLC ("Amzak Health"). The reporting person, a director of the Issuer, and Michael D. Kazma are managers of Amzak Health and, as a result, have shared voting and dispositive power over the shares held by Amzak Health. Ms. Erony disclaims beneficial ownership of the shares held by Amzak Health except to the extent of her proportionate pecuniary interest therein. Read SEC document |
| May 02, 2019 Filed May 6, 2019 22:03 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantStock Option (right to buy) · Derivative | 4,569 | $0.00 Strike: $49.96 | $0.00 |
DisclosureSEC source: 0001104659-19-027218 · a4.xml · derivative · entry 1 Erony Joyce · CIK 0001459212 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,569 Underlying: Common Stock · 4,569 shares Expires 2029-05-02 F1 · derivative.exercise_date: The option vests and becomes exercisable on May 2, 2020, subject to the Reporting Person's continuous service to the Issuer through such date. Read SEC document |
| February 05, 2019 Filed Feb 7, 2019 21:04 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 37,946 | $53.92 | $2,046,135.60 |
DisclosureSEC source: 0001213900-19-001832 · ownership.xml · nonDerivative · entry 1 Erony Joyce · CIK 0001459212 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 687,043 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Amzak Health Investors, LLC ("Amzak Health") on December 10, 2018. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.27 to $55.49. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are held of record by Amzak Health. The reporting person, a director of the Issuer, Michael D. Kazma, and Anders Hove are managers of Amzak Health and, as a result, have shared voting and dispositive power over the shares held by Amzak Health. Ms. Erony disclaims beneficial ownership of the shares held by Amzak Health except to the extent of her proportionate pecuniary interest therein. Read SEC document |
| February 04, 2019 Filed Feb 5, 2019 00:25 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 16,708 | $52.63 | $879,260.17 |
DisclosureSEC source: 0001213900-19-001655 · ownership.xml · nonDerivative · entry 3 Erony Joyce · CIK 0001459212 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 724,989 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Amzak Health Investors, LLC ("Amzak Health") on December 10, 2018. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.17 to $53.80. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F5 · ownership.nature: These shares are held of record by Amzak Health. The reporting person, a director of the Issuer, Michael D. Kazma, and Anders Hove are managers of Amzak Health and, as a result, have shared voting and dispositive power over the shares held by Amzak Health. Ms. Erony disclaims beneficial ownership of the shares held by Amzak Health except to the extent of her proportionate pecuniary interest therein. Read SEC document |
| February 01, 2019 Filed Feb 5, 2019 00:25 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 15,311 | $52.94 | $810,519.94 |
DisclosureSEC source: 0001213900-19-001655 · ownership.xml · nonDerivative · entry 2 Erony Joyce · CIK 0001459212 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 741,697 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Amzak Health Investors, LLC ("Amzak Health") on December 10, 2018. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.32 to $53.60. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F5 · ownership.nature: These shares are held of record by Amzak Health. The reporting person, a director of the Issuer, Michael D. Kazma, and Anders Hove are managers of Amzak Health and, as a result, have shared voting and dispositive power over the shares held by Amzak Health. Ms. Erony disclaims beneficial ownership of the shares held by Amzak Health except to the extent of her proportionate pecuniary interest therein. Read SEC document |
| January 31, 2019 Filed Feb 5, 2019 00:25 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 20,035 | $53.54 | $1,072,715.97 |
DisclosureSEC source: 0001213900-19-001655 · ownership.xml · nonDerivative · entry 1 Erony Joyce · CIK 0001459212 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 757,008 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Amzak Health Investors, LLC ("Amzak Health") on December 10, 2018. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.01 to $54.46. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F5 · ownership.nature: These shares are held of record by Amzak Health. The reporting person, a director of the Issuer, Michael D. Kazma, and Anders Hove are managers of Amzak Health and, as a result, have shared voting and dispositive power over the shares held by Amzak Health. Ms. Erony disclaims beneficial ownership of the shares held by Amzak Health except to the extent of her proportionate pecuniary interest therein. Read SEC document |
| January 30, 2019 Filed Jan 30, 2019 22:32 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 13,149 | $52.56 | $691,074.62 |
DisclosureSEC source: 0001213900-19-001457 · ownership.xml · nonDerivative · entry 3 Erony Joyce · CIK 0001459212 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 777,043 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Amzak Health Investors, LLC ("Amzak Health") on December 10, 2018. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.96 to $53.14. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F5 · ownership.nature: These shares are held of record by Amzak Health. The reporting person, a director of the Issuer, Michael D. Kazma, and Anders Hove are managers of Amzak Health and, as a result, have shared voting and dispositive power over the shares held by Amzak Health. Ms. Erony disclaims beneficial ownership of the shares held by Amzak Health except to the extent of her proportionate pecuniary interest therein. Read SEC document |
| January 29, 2019 Filed Jan 30, 2019 22:32 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 19,120 | $52.49 | $1,003,635.57 |
DisclosureSEC source: 0001213900-19-001457 · ownership.xml · nonDerivative · entry 2 Erony Joyce · CIK 0001459212 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 790,192 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Amzak Health Investors, LLC ("Amzak Health") on December 10, 2018. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.97 to $53.91. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F5 · ownership.nature: These shares are held of record by Amzak Health. The reporting person, a director of the Issuer, Michael D. Kazma, and Anders Hove are managers of Amzak Health and, as a result, have shared voting and dispositive power over the shares held by Amzak Health. Ms. Erony disclaims beneficial ownership of the shares held by Amzak Health except to the extent of her proportionate pecuniary interest therein. Read SEC document |
| January 28, 2019 Filed Jan 30, 2019 22:32 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 34,752 | $53.65 | $1,864,330.12 |
DisclosureSEC source: 0001213900-19-001457 · ownership.xml · nonDerivative · entry 1 Erony Joyce · CIK 0001459212 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 809,312 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Amzak Health Investors, LLC ("Amzak Health") on December 10, 2018. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.11 to $54.47. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F5 · ownership.nature: These shares are held of record by Amzak Health. The reporting person, a director of the Issuer, Michael D. Kazma, and Anders Hove are managers of Amzak Health and, as a result, have shared voting and dispositive power over the shares held by Amzak Health. Ms. Erony disclaims beneficial ownership of the shares held by Amzak Health except to the extent of her proportionate pecuniary interest therein. Read SEC document |
| January 25, 2019 Filed Jan 25, 2019 23:18 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 21,379 | $53.09 | $1,135,015.39 |
DisclosureSEC source: 0001213900-19-001279 · ownership.xml · nonDerivative · entry 4 Erony Joyce · CIK 0001459212 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 844,064 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Amzak Health Investors, LLC ("Amzak Health") on December 10, 2018. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.08 to $53.58. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F6 · ownership.nature: These shares are held of record by Amzak Health. The reporting person, a director of the Issuer, Michael D. Kazma, and Anders Hove are managers of Amzak Health and, as a result, have shared voting and dispositive power over the shares held by Amzak Health. Ms. Erony disclaims beneficial ownership of the shares held by Amzak Health except to the extent of her proportionate pecuniary interest therein. Read SEC document |
| January 24, 2019 Filed Jan 25, 2019 23:18 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 1,600 | $53.13 | $85,001.76 |
DisclosureSEC source: 0001213900-19-001279 · ownership.xml · nonDerivative · entry 3 Erony Joyce · CIK 0001459212 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 865,443 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Amzak Health Investors, LLC ("Amzak Health") on December 10, 2018. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.05 to $53.27. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F6 · ownership.nature: These shares are held of record by Amzak Health. The reporting person, a director of the Issuer, Michael D. Kazma, and Anders Hove are managers of Amzak Health and, as a result, have shared voting and dispositive power over the shares held by Amzak Health. Ms. Erony disclaims beneficial ownership of the shares held by Amzak Health except to the extent of her proportionate pecuniary interest therein. Read SEC document |
| January 24, 2019 Filed Jan 25, 2019 23:18 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 27,118 | $52.33 | $1,418,981.89 |
DisclosureSEC source: 0001213900-19-001279 · ownership.xml · nonDerivative · entry 2 Erony Joyce · CIK 0001459212 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 867,043 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Amzak Health Investors, LLC ("Amzak Health") on December 10, 2018. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.02 to $53.07. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F6 · ownership.nature: These shares are held of record by Amzak Health. The reporting person, a director of the Issuer, Michael D. Kazma, and Anders Hove are managers of Amzak Health and, as a result, have shared voting and dispositive power over the shares held by Amzak Health. Ms. Erony disclaims beneficial ownership of the shares held by Amzak Health except to the extent of her proportionate pecuniary interest therein. Read SEC document |
| January 23, 2019 Filed Jan 25, 2019 23:18 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 12,773 | $52.40 | $669,317.97 |
DisclosureSEC source: 0001213900-19-001279 · ownership.xml · nonDerivative · entry 1 Erony Joyce · CIK 0001459212 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 894,161 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Amzak Health Investors, LLC ("Amzak Health") on December 10, 2018. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.45 to $53.58. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F6 · ownership.nature: These shares are held of record by Amzak Health. The reporting person, a director of the Issuer, Michael D. Kazma, and Anders Hove are managers of Amzak Health and, as a result, have shared voting and dispositive power over the shares held by Amzak Health. Ms. Erony disclaims beneficial ownership of the shares held by Amzak Health except to the extent of her proportionate pecuniary interest therein. Read SEC document |
| January 22, 2019 Filed Jan 23, 2019 15:38 UTC Amendment | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 20,905 | $54.00 | $1,128,790.56 |
DisclosureSEC source: 0001213900-19-001093 · ownership.xml · nonDerivative · entry 6 Erony Joyce · CIK 0001459212 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 906,934 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Amzak Health Investors, LLC ("Amzak Health") on December 10, 2018. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.07 to $55.10. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F8 · ownership.nature: These shares are held of record by Amzak Health. The reporting person, a director of the Issuer, Michael D. Kazma, and Anders Hove are managers of Amzak Health and, as a result, have shared voting and dispositive power over the shares held by Amzak Health. Ms. Erony disclaims beneficial ownership of the shares held by Amzak Health except to the extent of her proportionate pecuniary interest therein. Read SEC document |
| January 18, 2019 Filed Jan 23, 2019 15:38 UTC Amendment | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 29,204 | $55.32 | $1,615,644.13 |
DisclosureSEC source: 0001213900-19-001093 · ownership.xml · nonDerivative · entry 5 Erony Joyce · CIK 0001459212 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 927,839 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Amzak Health Investors, LLC ("Amzak Health") on December 10, 2018. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.77 to $56.685. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F8 · ownership.nature: These shares are held of record by Amzak Health. The reporting person, a director of the Issuer, Michael D. Kazma, and Anders Hove are managers of Amzak Health and, as a result, have shared voting and dispositive power over the shares held by Amzak Health. Ms. Erony disclaims beneficial ownership of the shares held by Amzak Health except to the extent of her proportionate pecuniary interest therein. Read SEC document |
| January 18, 2019 Filed Jan 23, 2019 15:38 UTC Amendment | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 35,616 | $54.60 | $1,944,608.67 |
DisclosureSEC source: 0001213900-19-001093 · ownership.xml · nonDerivative · entry 4 Erony Joyce · CIK 0001459212 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 957,043 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Amzak Health Investors, LLC ("Amzak Health") on December 10, 2018. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.58 to $55.99. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F8 · ownership.nature: These shares are held of record by Amzak Health. The reporting person, a director of the Issuer, Michael D. Kazma, and Anders Hove are managers of Amzak Health and, as a result, have shared voting and dispositive power over the shares held by Amzak Health. Ms. Erony disclaims beneficial ownership of the shares held by Amzak Health except to the extent of her proportionate pecuniary interest therein. Read SEC document |
| January 17, 2019 Filed Jan 23, 2019 15:38 UTC Amendment | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 54,384 | $54.08 | $2,941,075.84 |
DisclosureSEC source: 0001213900-19-001093 · ownership.xml · nonDerivative · entry 3 Erony Joyce · CIK 0001459212 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 992,659 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Amzak Health Investors, LLC ("Amzak Health") on December 10, 2018. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.25 to $55.12. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F8 · ownership.nature: These shares are held of record by Amzak Health. The reporting person, a director of the Issuer, Michael D. Kazma, and Anders Hove are managers of Amzak Health and, as a result, have shared voting and dispositive power over the shares held by Amzak Health. Ms. Erony disclaims beneficial ownership of the shares held by Amzak Health except to the extent of her proportionate pecuniary interest therein. Read SEC document |
| January 17, 2019 Filed Jan 23, 2019 15:38 UTC Amendment | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 90,000 | $53.86 | $4,847,454.00 |
DisclosureSEC source: 0001213900-19-001093 · ownership.xml · nonDerivative · entry 2 Erony Joyce · CIK 0001459212 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,047,043 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Amzak Health Investors, LLC ("Amzak Health") on December 10, 2018. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.04 to $55.09. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F8 · ownership.nature: These shares are held of record by Amzak Health. The reporting person, a director of the Issuer, Michael D. Kazma, and Anders Hove are managers of Amzak Health and, as a result, have shared voting and dispositive power over the shares held by Amzak Health. Ms. Erony disclaims beneficial ownership of the shares held by Amzak Health except to the extent of her proportionate pecuniary interest therein. Read SEC document |
| January 17, 2019 Filed Jan 23, 2019 15:38 UTC Amendment | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 59,296 | $52.66 | $3,122,640.02 |
DisclosureSEC source: 0001213900-19-001093 · ownership.xml · nonDerivative · entry 1 Erony Joyce · CIK 0001459212 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,137,043 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Amzak Health Investors, LLC ("Amzak Health") on December 10, 2018. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.63 to $53.67. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F8 · ownership.nature: These shares are held of record by Amzak Health. The reporting person, a director of the Issuer, Michael D. Kazma, and Anders Hove are managers of Amzak Health and, as a result, have shared voting and dispositive power over the shares held by Amzak Health. Ms. Erony disclaims beneficial ownership of the shares held by Amzak Health except to the extent of her proportionate pecuniary interest therein. Read SEC document |
| January 16, 2019 Filed Jan 23, 2019 15:36 UTC Amendment | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 67,432 | $50.13 | $3,380,608.92 |
DisclosureSEC source: 0001213900-19-001091 · ownership.xml · nonDerivative · entry 6 Erony Joyce · CIK 0001459212 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,196,339 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Amzak Health Investors, LLC ("Amzak Health") on December 10, 2018. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.23 to $51.26. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F8 · ownership.nature: These shares are held of record by Amzak Health. The reporting person, a director of the Issuer, Michael D. Kazma, and Anders Hove are managers of Amzak Health and, as a result, have shared voting and dispositive power over the shares held by Amzak Health. The reporting person disclaims beneficial ownership of the shares held by Amzak Health except to the extent of her proportionate pecuniary interest therein. Read SEC document |
| January 16, 2019 Filed Jan 23, 2019 15:36 UTC Amendment | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 30,704 | $50.83 | $1,560,546.15 |
DisclosureSEC source: 0001213900-19-001091 · ownership.xml · nonDerivative · entry 5 Erony Joyce · CIK 0001459212 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,263,771 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Amzak Health Investors, LLC ("Amzak Health") on December 10, 2018. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.455 to $51.435. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F8 · ownership.nature: These shares are held of record by Amzak Health. The reporting person, a director of the Issuer, Michael D. Kazma, and Anders Hove are managers of Amzak Health and, as a result, have shared voting and dispositive power over the shares held by Amzak Health. The reporting person disclaims beneficial ownership of the shares held by Amzak Health except to the extent of her proportionate pecuniary interest therein. Read SEC document |
| January 15, 2019 Filed Jan 23, 2019 15:36 UTC Amendment | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 22,568 | $49.27 | $1,111,889.25 |
DisclosureSEC source: 0001213900-19-001091 · ownership.xml · nonDerivative · entry 4 Erony Joyce · CIK 0001459212 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,294,475 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Amzak Health Investors, LLC ("Amzak Health") on December 10, 2018. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.945 to $49.50. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F8 · ownership.nature: These shares are held of record by Amzak Health. The reporting person, a director of the Issuer, Michael D. Kazma, and Anders Hove are managers of Amzak Health and, as a result, have shared voting and dispositive power over the shares held by Amzak Health. The reporting person disclaims beneficial ownership of the shares held by Amzak Health except to the extent of her proportionate pecuniary interest therein. Read SEC document |
| January 15, 2019 Filed Jan 23, 2019 15:36 UTC Amendment | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 90,000 | $48.82 | $4,393,584.00 |
DisclosureSEC source: 0001213900-19-001091 · ownership.xml · nonDerivative · entry 3 Erony Joyce · CIK 0001459212 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,317,043 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Amzak Health Investors, LLC ("Amzak Health") on December 10, 2018. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.11 to $49.43. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F8 · ownership.nature: These shares are held of record by Amzak Health. The reporting person, a director of the Issuer, Michael D. Kazma, and Anders Hove are managers of Amzak Health and, as a result, have shared voting and dispositive power over the shares held by Amzak Health. The reporting person disclaims beneficial ownership of the shares held by Amzak Health except to the extent of her proportionate pecuniary interest therein. Read SEC document |
| January 15, 2019 Filed Jan 23, 2019 15:36 UTC Amendment | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 2,000 | $48.03 | $96,053.80 |
DisclosureSEC source: 0001213900-19-001091 · ownership.xml · nonDerivative · entry 2 Erony Joyce · CIK 0001459212 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,407,043 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Amzak Health Investors, LLC ("Amzak Health") on December 10, 2018. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.11 to $48.37. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F8 · ownership.nature: These shares are held of record by Amzak Health. The reporting person, a director of the Issuer, Michael D. Kazma, and Anders Hove are managers of Amzak Health and, as a result, have shared voting and dispositive power over the shares held by Amzak Health. The reporting person disclaims beneficial ownership of the shares held by Amzak Health except to the extent of her proportionate pecuniary interest therein. Read SEC document |
| January 14, 2019 Filed Jan 23, 2019 15:36 UTC Amendment | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 88,000 | $48.69 | $4,284,420.80 |
DisclosureSEC source: 0001213900-19-001091 · ownership.xml · nonDerivative · entry 1 Erony Joyce · CIK 0001459212 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,409,043 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Amzak Health Investors, LLC ("Amzak Health") on December 10, 2018. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.515 to $49.50. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F8 · ownership.nature: These shares are held of record by Amzak Health. The reporting person, a director of the Issuer, Michael D. Kazma, and Anders Hove are managers of Amzak Health and, as a result, have shared voting and dispositive power over the shares held by Amzak Health. The reporting person disclaims beneficial ownership of the shares held by Amzak Health except to the extent of her proportionate pecuniary interest therein. Read SEC document |
| May 07, 2018 Filed May 10, 2018 01:16 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | ConversionSeries F Convertible Preferred Stock · Derivative | 9,124,088 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-18-031860 · a4.xml · derivative · entry 3 Erony Joyce · CIK 0001459212 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Common Stock · 1,372,043 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Shares of Series F Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock at a 1-for-0.1504 conversion rate immediately prior to the closing of the Issuer's initial public offering for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Issuer's Sixth Amended and Restated Certificate of Incorporation, as amended). These shares had no expiration date. F1 · derivative.exercise_date: Shares of Series F Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock at a 1-for-0.1504 conversion rate immediately prior to the closing of the Issuer's initial public offering for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Issuer's Sixth Amended and Restated Certificate of Incorporation, as amended). These shares had no expiration date. F1 · derivative.expiration_date: Shares of Series F Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock at a 1-for-0.1504 conversion rate immediately prior to the closing of the Issuer's initial public offering for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Issuer's Sixth Amended and Restated Certificate of Incorporation, as amended). These shares had no expiration date. F2 · ownership.nature: These shares are held of record by Amzak Health Investors, LLC ("Amzak Health"). Joyce Erony, a director of the Issuer, Michael D. Kazma, and Anders Hove are managers of Amzak Health and, as a result, have shared voting and dispositive power over the shares held by Amzak Health. Ms. Erony disclaims beneficial ownership of the shares held by Amzak Health except to the extent of her proportionate pecuniary interest therein. Read SEC document |
| May 07, 2018 Filed May 10, 2018 01:16 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | PurchaseCommon Stock | 125,000 | $16.00 | $2,000,000.00 |
DisclosureSEC source: 0001104659-18-031860 · a4.xml · nonDerivative · entry 2 Erony Joyce · CIK 0001459212 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,497,043 F2 · ownership.nature: These shares are held of record by Amzak Health Investors, LLC ("Amzak Health"). Joyce Erony, a director of the Issuer, Michael D. Kazma, and Anders Hove are managers of Amzak Health and, as a result, have shared voting and dispositive power over the shares held by Amzak Health. Ms. Erony disclaims beneficial ownership of the shares held by Amzak Health except to the extent of her proportionate pecuniary interest therein. Read SEC document |
| May 07, 2018 Filed May 10, 2018 01:16 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | ConversionCommon Stock | 1,372,043 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-18-031860 · a4.xml · nonDerivative · entry 1 Erony Joyce · CIK 0001459212 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,372,043 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Shares of Series F Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock at a 1-for-0.1504 conversion rate immediately prior to the closing of the Issuer's initial public offering for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Issuer's Sixth Amended and Restated Certificate of Incorporation, as amended). These shares had no expiration date. F2 · ownership.nature: These shares are held of record by Amzak Health Investors, LLC ("Amzak Health"). Joyce Erony, a director of the Issuer, Michael D. Kazma, and Anders Hove are managers of Amzak Health and, as a result, have shared voting and dispositive power over the shares held by Amzak Health. Ms. Erony disclaims beneficial ownership of the shares held by Amzak Health except to the extent of her proportionate pecuniary interest therein. Read SEC document |
| January 22, 2018 Filed Jan 22, 2019 23:31 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 20,905 | $54.00 | $1,128,790.56 |
DisclosureSEC source: 0001213900-19-001071 · ownership.xml · nonDerivative · entry 6 Erony Joyce · CIK 0001459212 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 906,934 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Amzak Health Investors, LLC ("Amzak Health") on December 10, 2018. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.07 to $55.10. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F8 · ownership.nature: These shares are held of record by Amzak Health. The reporting person, a director of the Issuer, Michael D. Kazma, and Anders Hove are managers of Amzak Health and, as a result, have shared voting and dispositive power over the shares held by Amzak Health. Ms. Erony disclaims beneficial ownership of the shares held by Amzak Health except to the extent of her proportionate pecuniary interest therein. Read SEC document |
| January 18, 2018 Filed Jan 22, 2019 23:31 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 29,204 | $55.32 | $1,615,644.13 |
DisclosureSEC source: 0001213900-19-001071 · ownership.xml · nonDerivative · entry 5 Erony Joyce · CIK 0001459212 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 927,839 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Amzak Health Investors, LLC ("Amzak Health") on December 10, 2018. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.77 to $56.685. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F8 · ownership.nature: These shares are held of record by Amzak Health. The reporting person, a director of the Issuer, Michael D. Kazma, and Anders Hove are managers of Amzak Health and, as a result, have shared voting and dispositive power over the shares held by Amzak Health. Ms. Erony disclaims beneficial ownership of the shares held by Amzak Health except to the extent of her proportionate pecuniary interest therein. Read SEC document |
| January 18, 2018 Filed Jan 22, 2019 23:31 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 35,616 | $54.60 | $1,944,608.67 |
DisclosureSEC source: 0001213900-19-001071 · ownership.xml · nonDerivative · entry 4 Erony Joyce · CIK 0001459212 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 957,043 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Amzak Health Investors, LLC ("Amzak Health") on December 10, 2018. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.58 to $55.99. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F8 · ownership.nature: These shares are held of record by Amzak Health. The reporting person, a director of the Issuer, Michael D. Kazma, and Anders Hove are managers of Amzak Health and, as a result, have shared voting and dispositive power over the shares held by Amzak Health. Ms. Erony disclaims beneficial ownership of the shares held by Amzak Health except to the extent of her proportionate pecuniary interest therein. Read SEC document |
| January 17, 2018 Filed Jan 22, 2019 23:31 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 54,384 | $54.08 | $2,941,075.84 |
DisclosureSEC source: 0001213900-19-001071 · ownership.xml · nonDerivative · entry 3 Erony Joyce · CIK 0001459212 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 992,659 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Amzak Health Investors, LLC ("Amzak Health") on December 10, 2018. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.25 to $55.12. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F8 · ownership.nature: These shares are held of record by Amzak Health. The reporting person, a director of the Issuer, Michael D. Kazma, and Anders Hove are managers of Amzak Health and, as a result, have shared voting and dispositive power over the shares held by Amzak Health. Ms. Erony disclaims beneficial ownership of the shares held by Amzak Health except to the extent of her proportionate pecuniary interest therein. Read SEC document |
| January 17, 2018 Filed Jan 22, 2019 23:31 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 90,000 | $53.86 | $4,847,454.00 |
DisclosureSEC source: 0001213900-19-001071 · ownership.xml · nonDerivative · entry 2 Erony Joyce · CIK 0001459212 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,047,043 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Amzak Health Investors, LLC ("Amzak Health") on December 10, 2018. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.04 to $55.09. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F8 · ownership.nature: These shares are held of record by Amzak Health. The reporting person, a director of the Issuer, Michael D. Kazma, and Anders Hove are managers of Amzak Health and, as a result, have shared voting and dispositive power over the shares held by Amzak Health. Ms. Erony disclaims beneficial ownership of the shares held by Amzak Health except to the extent of her proportionate pecuniary interest therein. Read SEC document |
| January 17, 2018 Filed Jan 22, 2019 23:31 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 59,296 | $52.66 | $3,122,640.02 |
DisclosureSEC source: 0001213900-19-001071 · ownership.xml · nonDerivative · entry 1 Erony Joyce · CIK 0001459212 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,137,043 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Amzak Health Investors, LLC ("Amzak Health") on December 10, 2018. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.63 to $53.67. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F8 · ownership.nature: These shares are held of record by Amzak Health. The reporting person, a director of the Issuer, Michael D. Kazma, and Anders Hove are managers of Amzak Health and, as a result, have shared voting and dispositive power over the shares held by Amzak Health. Ms. Erony disclaims beneficial ownership of the shares held by Amzak Health except to the extent of her proportionate pecuniary interest therein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.